bar

Rathmell to direct Division of Hematology and Oncology

W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology. Read More

Time-Honored Events Put the ‘Fun’ in Fundraising

Four of the longest-running fundraisers for Vanderbilt University Medical Center are also local Nashville traditions. Iroquois Steeplechase, the Music City Tennis Invitational (MCTI), Eve of Janus and Christmas Village collectively have contributed more than $20 million to VUMC. Read More

Eleven faculty honored with endowed chairs

Eleven Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration April 30 at the Student Life Center. Read More

Events have long history of making a huge impact

They are touchstones on the Nashville calendar — Iroquois Steeplechase and the Music City Tennis Invitational usher in spring. The Eve of Janus is a celebration of summer. Christmas Village kicks off the holiday season. Read More

Komen grants bolster breast cancer research

Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read More

Clayton, Frangoul elected to American Pediatric Society

Ellen Wright Clayton, M.D., J.D., Craig-Weaver Professor of Pediatrics and Professor of Law, and Haydar Frangoul, M.D., Carolyn Perot Rathjen Chair and Professor of Pediatrics have been elected to the American Pediatric Society (APS). Read More

Tri Deltas Mark 40 Years of Supporting Children

Six-year-old cancer patient Alex Kallas checks out the playroom at the Monroe Carell Jr. Children’s Hospital at Vanderbilt. The cure rate for childhood cancers has… Read More

Discussion on melanoma set for July 27

With the peak of summer approaching, Vanderbilt researchers will discuss innovative research on melanoma and how new insights could lead to less toxic treatments and better outcomes for patients. “Toward a Cure for Melanoma” will take place on Tuesday, July 27, at noon CT. Read More

Undergraduates get in-depth look at approaches to cancer treatment through virtual tumor boards

Vanderbilt’s Health Professions Advisory Office, in collaboration with faculty at Vanderbilt-Ingram Cancer Center, gave a group of undergraduate students a firsthand look at how physicians approach specialized cancer treatment. The students were given the opportunity to participate in a series of virtual “tumor boards.” Read More

Personalized Structural Biology aids cancer treatment decisions

Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Read More

Vanderbilt experts discuss colorectal cancer research progress in virtual event

In recognition of Colorectal Cancer Awareness Month, the School of Medicine Basic Sciences will host a panel discussion, "On the Cutting Edge: Research Toward a Cure for Colorectal Cancer,” on Tuesday, March 30, from 11 a.m. to noon CT. Read More

Post-transplant diabetes may be reversible: study

Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report. Read More

Center for Immunobiology grows, bolsters program

The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence. Read More

Study identifies critical regulator of tumor-specific T cell differentiation

A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work Read More

Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology. Read More

Investigators map genomic landscape of very rare cancer

A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer. Read More

Research explores link between stem cell transplant, diabetes

Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes. Read More

Hyundai Hope on Wheels keeps cancer research support rolling

Debra Friedman, MD, director of the Division of Pediatric Hematology/Oncology, has been awarded a $100,000 Hyundai Hope on Wheels Impact Award. The grant was celebrated in a “handprint ceremony” with Hyundai representatives on June 12. Read More

Jagasia to succeed Neuss as VICC Chief Medical Officer

After successfully leading Vanderbilt-Ingram Cancer Center (VICC) through years of growth in patient volumes and enhanced care options, Michael Neuss, MD, Chief Medical Officer of the VICC Clinical Enterprise, is retiring as CMO. Neuss will be succeeded by Madan Jagasia, MBBS, MSCI, MMHC, who has been named to the George and Beverley Rawlings Directorship and is section chief, Hematology and Stem Cell Transplant and director of the Outpatient Stem Cell Clinic. Read More

Faculty meeting recognizes excellence in education, research and clinical service

During Wednesday’s Spring Faculty Meeting, Jeff Balser, M.D., Ph.D., dean of Vanderbilt University School of Medicine and President and CEO of Vanderbilt University Medical Center, highlighted the medical school’s rising stature among the country’s top-tier institutions. Read More